<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Schiraldi, Milena</dc:creator>
  <dc:creator>Raucci, Angela</dc:creator>
  <dc:creator>Martínez Muñoz, Laura</dc:creator>
  <dc:creator>Livoti, Elsa</dc:creator>
  <dc:creator>Celona, Barbara</dc:creator>
  <dc:creator>Venereau, Emilie</dc:creator>
  <dc:creator>Apuzzo, Tiziana</dc:creator>
  <dc:creator>De Marchis, Francesco</dc:creator>
  <dc:creator>Pedotti, Mattia</dc:creator>
  <dc:creator>Bachi, Angela</dc:creator>
  <dc:creator>Thelen, Marcus</dc:creator>
  <dc:creator>Varani, Luca</dc:creator>
  <dc:creator>Mellado, Mario</dc:creator>
  <dc:creator>Proudfoot, Amanda</dc:creator>
  <dc:creator>Bianchi, Marco Emilio</dc:creator>
  <dc:creator>Uguccioni, Mariagrazia</dc:creator>
  <dc:date>2012-02-27</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">After tissue damage, inflammatory cells infiltrate the tissue and release proinflammatory  cytokines. HMGB1 (high mobility group box 1), a nuclear protein released by necrotic and  severely stressed cells, promotes cytokine release via its interaction with the TLR4 (Toll-like  receptor 4) receptor and cell migration via an unknown mechanism. We show that HMGB1- induced recruitment of inflammatory cells depends on CXCL12. HMGB1 and CXCL12 form a  heterocomplex, which we characterized by nuclear magnetic resonance and surface plasmon  resonance, that acts exclusively through CXCR4 and not through other HMGB1 receptors.  Fluorescence resonance energy transfer data show that the HMGB1–CXCL12 heterocomplex  promotes different conformational rearrangements of CXCR4 from that of CXCL12 alone.  Mononuclear cell recruitment in vivo into air pouches and injured muscles depends on the  heterocomplex and is inhibited by AMD3100 and glycyrrhizin. Thus, inflammatory cell  recruitment and activation both depend on HMGB1 via different mechanisms.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1318882</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/318882</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/318882/files/Schiraldi_JEM_2012.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1084/jem.20111739</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1318882</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY-NC-SA</dc:rights>
  <dc:source>The journal of experimental medicine. - 2012, vol. 209, no. 3, p. 551-563</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
